---
title: 'Pregnancy and Elevated Factor VIII'
hide_page_title: false
show_sidebar: false
hide_git_sync_repo_link: false
---

Hereditary deficiency of clotting factor VIII is called hemophilia A, which occurs most often in men; women are carriers of the disease.

Recently, we are increasingly encountering situations where women are prescribed testing of factor VIII levels to rule out elevation. ğŸ¤·â€â™€ï¸
This recommendation is based on the assumption that high levels of factor VIII lead to thrombosis (and this does have some support â€” when ultra-high doses of factor VIII are given even to patients with hemophilia, thrombosis may indeed occur ğŸ§â€â™€ï¸).

So, is it really necessary to measure factor VIII levels when investigating pregnancy loss or thrombosis?

Normal activity of factor VIII (Abbassi-Ghanavati M et al., 2009):
ğŸ”´ General population: 50â€“150%
ğŸ”´ 1st trimester: 90â€“210%
ğŸ”´ 2nd trimester: 97â€“312%
ğŸ”´ 3rd trimester: 143â€“353%

Elevation of factor VIII activity is physiological in pregnancy ğŸ§â€â™‚ï¸ and is most pronounced closer to delivery.

In earlier publications (up to the mid-2010s), based on small and mostly retrospective studies, conclusions were drawn that factor VIII >150% increases the risk of early miscarriages.
However, in more robust prospective studies, this association has not been confirmed. ğŸ‘

ğŸ‘‰ Therefore, for the purpose of diagnosing thrombophilia, measuring factor VIII activity â€” especially during pregnancy â€” is not meaningful. â›”âš ï¸